- QMRO Home
- Blizard Institute
- Centre for Neuroscience, Surgery and Trauma
- CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
Browse
Administrators only